Skip to main content
. 2012 May 17;103(7):1327–1333. doi: 10.1111/j.1349-7006.2012.02292.x

Table 2.

Correlation between collagen triple helix repeat containing 1 (CTHRC1) immunoreactivity and clinical parameters in gastric cancer tissues

Cases (n = 116) CTHRC1 CTHRC1 P‐value
Positive n (%) Negative n (%)
Differentiation
Well or moderate 50 36 (72.0) 14 (28.0) 0.34
Poor (or no differentiation) 66 42 (78.0) 24 (38.0)
Lauren type
Diffuse 47 27 (57.4) 20 (42.6) 0.80
Intestinal 69 38 (55.1) 31 (44.9)
Depth of invasion
T1/T2 70 42 (60.0) 28 (40.0) 0.04
T3/T4 46 36 (78.3) 10 (21.7)
Lymph node metastasis
63 40 (63.5) 23 (36.5) 0.35
+ 53 38 (71.7) 15 (28.3)
Size (cm)
<5 75 48 (64.0) 27 (36.0) 0.31
≥5 41 30 (73.1) 11 (26.8)

P‐value was calculated according to the Pearson's chi‐square‐test. Bold P‐value means that a significant correlation was found between increased CTHRC1 expression and the depth of invasion.